Citation Impact
Citing Papers
Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases
2011 Standout
Reciprocal Activation of Prostate Cancer Cells and Cancer-Associated Fibroblasts Stimulates Epithelial-Mesenchymal Transition and Cancer Stemness
2010
Molecular Alterations in Primary Prostate Cancer after Androgen Ablation Therapy
2005
Acute toxicity of textile dye wastewaters (untreated and treated) of Sanganer on male reproductive systems of albino rats and mice
2005
Comprehensive molecular portraits of human breast tumours
2012 StandoutNature
Basal cell carcinomas: attack of the hedgehog
2008 Standout
Muscle satellite cells are a functionally heterogeneous population in both somite-derived and branchiomeric muscles
2009
Role of JNK/ATF-2 pathway in inhibition of thrombospondin-1 (TSP-1) expression and apoptosis mediated by doxorubicin and camptothecin in FTC-133 cells
2011 StandoutNobel
Prostate tumor progression is mediated by a paracrine TGF-β/Wnt3a signaling axis
2008
Estrogen receptors and human disease
2006 Standout
Skeletal Muscle Fatigue: Cellular Mechanisms
2008 Standout
The role of ATF‐2 in oncogenesis
2008
Role of estrogens in development of prostate cancer
2004
Hepatocellular carcinoma
2016 Standout
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
Signal integration by JNK and p38 MAPK pathways in cancer development
2009 Standout
Smad transcription factors
2005 Standout
p38 MAP kinase signaling is necessary for rat chondrosarcoma cell proliferation
2004
Interleukin-6 signaling pathway in targeted therapy for cancer
2012
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Lower levels of nuclear β‐catenin predict for a poorer prognosis in localized prostate cancer
2004
Fungal adaptation to the mammalian host: it is a new world, after all
2008
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
Benign prostatic hyperplasia: age-related tissue-remodeling
2005
The biology and function of fibroblasts in cancer
2016 Standout
The mini-driver model of polygenic cancer evolution
2015 StandoutNobel
Arrestin Development: Emerging Roles for β-arrestins in Developmental Signaling Pathways
2009 StandoutNobel
DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells
2005 Standout
Mcl-1 is Regulated by IL-6 and Mediates the Survival Activity of the Cytokine in a Model of Late Stage Prostate Carcinoma
2008
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: A snapshot of IL-6 mediated involvement
2016
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Role of interleukin-6 in cancer progression and therapeutic resistance
2016
Inflammation: Gearing the journey to cancer
2008
Therapeutic approaches for muscle wasting disorders
2006
MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study
2017
Resveratrol Antagonizes EGFR-Dependent Erk1/2 Activation in Human Androgen-Independent Prostate Cancer Cells with Associated Isozyme-Selective PKCα Inhibition
2004
A critical review on the treatment of dye-containing wastewater: Ecotoxicological and health concerns of textile dyes and possible remediation approaches for environmental safety
2022 Standout
Targeting apoptosis in cancer therapy
2020 Standout
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
The role of intratumoral and systemic IL-6 in breast cancer
2013
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Inflammasomes: mechanism of assembly, regulation and signalling
2016 Standout
Anti‐proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: Implication of epidermal growth factor receptor down‐regulation and ceramide production
2003
The evolution of cell types in animals: emerging principles from molecular studies
2008
Oxidative Stress in Cancer
2020 Standout
Occurrence of urolithins, gut microbiota ellagic acid metabolites and proliferation markers expression response in the human prostate gland upon consumption of walnuts and pomegranate juice
2009
Cytotoxic effects induced by a combination of cyclopamine and gefitinib, the selective hedgehog and epidermal growth factor receptor signaling inhibitors, in prostate cancer cells
2005
Clinical trials of antioxidants as cancer prevention agents: Past, present, and future
2011
IL-6 and related cytokines as the critical lynchpins between inflammation and cancer
2014
CXCL12 overexpression and secretion by aging fibroblasts enhance human prostate epithelial proliferation in vitro
2005
Magnesium and cancer: a dangerous liason
2011
Cancer-related inflammation and treatment effectiveness
2014 Standout
Ellagic acid induces cell cycle arrest and apoptosis through TGF-β/Smad3 signaling pathway in human breast cancer MCF-7 cells
2015
LIF Mediates Proinvasive Activation of Stromal Fibroblasts in Cancer
2014
Immunity to fungal infections
2011 Standout
Cancer as an evolutionary and ecological process
2006 Standout
Lack of Expression of EGF and TGF- in the Fetal Mouse Alters Formation of Prostatic Epithelial Buds and Influences the Response to TCDD
2003
Epidermal growth factor receptor (EGFR) signaling in cancer
2005 Standout
Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases
2005
Muscles, exercise and obesity: skeletal muscle as a secretory organ
2012 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
A Perivascular Niche for Brain Tumor Stem Cells
2007 Standout
Dietary (Poly)phenolics in Human Health: Structures, Bioavailability, and Evidence of Protective Effects Against Chronic Diseases
2012 Standout
Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer
2006 Standout
Paradoxical Roles of Tumour Necrosis Factor-Alpha in Prostate Cancer Biology
2012
Magnesium in Man: Implications for Health and Disease
2014 Standout
The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression
2010 Standout
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
2009 Standout
β-Arrestin Deficiency Protects Against Pulmonary Fibrosis in Mice and Prevents Fibroblast Invasion of Extracellular Matrix
2011 StandoutNobel
AIM2, an IFN-Inducible Cytosolic DNA Sensor, in the Development of Benign Prostate Hyperplasia and Prostate Cancer
2013
The extracellular matrix at a glance
2010 Standout
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
2017 Standout
Acquisition of Stable Inducible Up-Regulation of Nuclear Factor-κB by Tumor Necrosis Factor Exposure Confers Increased Radiation Resistance without Increased Transformation in Breast Cancer Cells
2008
Exercise-induced muscle-derived cytokines inhibit mammary cancer cell growth
2011
Bioactive Compounds and Antioxidant Activity in Different Types of Berries
2015 Standout
Regeneratedmdxmouse skeletal muscle shows differential mRNA expression
2002
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
2020 Standout
SMAD3 represses androgen receptor-mediated transcription.
2001
A Switch from E-Cadherin to N-Cadherin Expression Indicates Epithelial to Mesenchymal Transition and Is of Strong and Independent Importance for the Progress of Prostate Cancer
2007
eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
2018 Standout
Evolutionary games on graphs
2007 Standout
Preclinical studies with Erlotinib (Tarceva)
2003
SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS
2005 Standout
Molecular targets of dietary agents for prevention and therapy of cancer
2006 Standout
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
Cellular and Molecular Regulation of Muscle Regeneration
2004 Standout
Evolution of cooperation among tumor cells
2006
Cell Adhesion Proteins As Tumor Suppressors
2002
Dual Faces of IFNγ in Cancer Progression: A Role of PD-L1 Induction in the Determination of Pro- and Antitumor Immunity
2016
Differential gene expression in tumor adjacent histologically normal prostatic tissue indicates field cancerization
2009
Works of Mar Royuela being referenced
TNF/IL‐1/NIK/NF‐κB transduction pathway: a comparative study in normal and pathological human prostate (benign hyperplasia and carcinoma)
2008
E-, N- And P-cadherin, and α-, β- and γ-catenin Protein Expression in Normal, Hyperplastic and Carcinomatous Human Prostate
2000
Estrogen receptors alpha and beta in the normal, hyperplastic and carcinomatous human prostate
2001
Interleukin‐1 (IL‐1α and IL‐1β) and its receptors (IL‐1RI, IL‐1RII, and IL‐1Ra) in prostate carcinoma
2004
IL‐6, its receptors and its relationship with bcl‐2 and bax proteins in infiltrating and in situ human breast carcinoma
2005
Influence of IFN-gamma and its receptors in human breast cancer
2007
Characterization of several invertebrate muscle cell types: a comparison with vertebrate muscles
2000
Regulation of proliferation/apoptosis equilibrium by mitogen-activated protein kinases in normal, hyperplastic, and carcinomatous human prostate
2002
The p38 transduction pathway in prostatic neoplasia
2005
IMMUNOEXPRESSION OF TUMOUR NECROSIS FACTOR-α AND ITS RECEPTORS 1 AND 2 CORRELATES WITH PROLIFERATION/APOPTOSIS EQUILIBRIUM IN NORMAL, HYPERPLASIC AND CARCINOMATOUS HUMAN PROSTATE
2000
Transforming Growth Factor β and its Receptor Types I and II. Comparison in Human Normal Prostate, Benign Prostatic Hyperplasia, and Prostatic Carcinoma
1998
IMMUNOHISTOCHEMICAL COMPARATIVE ANALYSIS OF TRANSFORMING GROWTH FACTOR α, EPIDERMAL GROWTH FACTOR, AND EPIDERMAL GROWTH FACTOR RECEPTOR IN NORMAL, HYPERPLASTIC AND NEOPLASTIC HUMAN PROSTATES
1999
Immunohistochemical analysis of the IL‐6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate
2003
Ability to grow on lipids accounts for the fully virulent phenotype in neutropenic mice of Aspergillus fumigatus null mutants in the key glyoxylate cycle enzymes
2007
Role of tumor necrosis factor‐α and its receptors in human benign breast lesions and tumors (in situ and infiltrative)
2006
Pro-inflammatory cytokines and prostate-specific antigen in hyperplasia and human prostate cancer
2008
OSM, LIF, Its Receptors, and Its Relationship with the Malignance in Human Breast Carcinoma (In Situand in Infiltrative)
2008
Morphometric evaluation of the human prostate
2001
Pro-Apoptotic Tumor Necrosis Factor-α Transduction Pathway In Normal Prostate, Benign Prostatic Hyperplasia And Prostatic Carcinoma
2003
Immunohistochemical detection of the retinoid X receptors alpha, beta, and gamma in human prostate.
2003
MAP Kinases and Prostate Cancer
2011
TNF-alpha/IL-1/NF-kappaB transduction pathway in human cancer prostate.
2008
Immunoexpressions of p21, Rb, mcl-1 and bad gene products in normal, hyperplastic and carcinomatous human prostates.
2002
Interferon-gamma and its functional receptors overexpression in benign prostatic hyperplasia and prostatic carcinoma: parallelism with c-myc and p53 expression.
2000
Comparative evolution of muscular dystrophy in diaphragm, gastrocnemius and masseter muscles from old male mdx mice
2001